Get started
Author

Stefanie Bolte

Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
2017 · Ugur Sahin, Evelyna Derhovanessian, et al. · Nature · 2,481
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
2020 · Ugur Sahin, Alexander Muik, et al. · Nature · 1,976
PDF
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
2021 · Ugur Sahin, Alexander Muik, et al. · Nature · 913
PDF
The liver stage of Plasmodium berghei inhibits host cell apoptosis
2005 · Claudia van de Sand, Sebastian Horstmann, et al. · Molecular Microbiology · 160
Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres
2015 · Benjamin Mordmüller, Christian Supan, et al. · Malaria Journal · 145
PDF
Alteration of the Parasite Plasma Membrane and the Parasitophorous Vacuole Membrane during Exo-Erythrocytic Development of Malaria Parasites
2008 · Angelika Sturm, Stefanie Graewe, et al. · Protist · 72
Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial
2016 · Peter G. Kremsner, Akim A. Adegnika, et al. · PLoS Medicine · 51
PDF
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC
2026 · U. Sahin, M. Schmidt, et al. · Nature · 47
88MO T-cell responses induced by an individualized neoantigen specific immune therapy in post (neo)adjuvant patients with triple negative breast cancer
2020 · M. Schmidt, I. Vogler, et al. · Annals of Oncology · 35
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
2021 · Ugur Sahin, Alexander Muik, et al. · Nature · 31
PDF
Immunization with a Circumsporozoite Epitope Fused to Bordetella pertussis Adenylate Cyclase in Conjunction with Cytotoxic T-Lymphocyte-Associated Antigen 4 Blockade Confers Protection against Plasmodium berghei Liver-Stage Malaria
2006 · Susanne Tartz, Jana Kamanova, et al. · Infection and Immunity · 24
IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma
2017 · M. Miller, U. Sahin, et al. · Annals of Oncology · 15
Abstract OT2-06-01: Highly innovative personalized RNA-immunotherapy for patients with triple negative breast cancer
2019 · M Schmidt, S Bolte, et al. · Cancer Research · 10
Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)
2018 · L. Heesen, K. Frenzel, et al. · Annals of Oncology · 4
Abstract CT221: Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)
2019 · Ludwig Heesen, Katrin Frenzel, et al. · Cancer Research · 3
Abstract CT221: Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)
2019 · Ludwig Heesen, Katrin Frenzel, et al. · Clinical Trials · 2
Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer
2017 · K. Frenzel, L. Heesen, et al. · Annals of Oncology · 2
PDF
Author Correction: BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
2025 · Uğur Şahin, Alexander Muik, et al. · Nature · 1
PDF
Abstract CT022: IVAC® MUTANOME - A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma
2016 · Matthias Miller, Carmen Loquai, et al. · Cancer Research
Parasiten-induzierte Phosphorylierungsereignisse in Plasmodium berghei [Vincke&Lips, 1948]-infizierten Hepatozyten
2006 · Stefanie Bolte
Works count: 21
Citation count: 5,968
H-index: 12
I10-index: 13
Year
Topic
Type